drugset / Trial / NCT06951945

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity

NCT06951945 ↗

Phase 1 Completed 36 enrolled Tonghua Dongbao Pharmaceutical Co.,Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this trial is to investigate the safety, tolerability, pharmacokinetics, and efficacy of THDBH120 injection in participants with obesity. This study includes three multiple-ascending dose cohorts.

Timeline

Start
2024-07-18
Primary completion
2024-12-23
Completion
2024-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject THDBH120 Unknown — Subcutaneous

Indications